Cargando…

P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)

Detalles Bibliográficos
Autores principales: Nørgaard, J. N., Abildgaard, N., Lysén, A., Tsykunova, G., Vangsted, A. J., Joao, C., Remen, N., Osnes, L., Connelly, J. P., Revheim, M.-E. R., Schjesvold, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429246/
http://dx.doi.org/10.1097/01.HS9.0000846620.98940.79
_version_ 1784779380246970368
author Nørgaard, J. N.
Abildgaard, N.
Lysén, A.
Tsykunova, G.
Vangsted, A. J.
Joao, C.
Remen, N.
Osnes, L.
Connelly, J. P.
Revheim, M.-E. R.
Schjesvold, F.
author_facet Nørgaard, J. N.
Abildgaard, N.
Lysén, A.
Tsykunova, G.
Vangsted, A. J.
Joao, C.
Remen, N.
Osnes, L.
Connelly, J. P.
Revheim, M.-E. R.
Schjesvold, F.
author_sort Nørgaard, J. N.
collection PubMed
description
format Online
Article
Text
id pubmed-9429246
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94292462022-08-31 P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET) Nørgaard, J. N. Abildgaard, N. Lysén, A. Tsykunova, G. Vangsted, A. J. Joao, C. Remen, N. Osnes, L. Connelly, J. P. Revheim, M.-E. R. Schjesvold, F. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429246/ http://dx.doi.org/10.1097/01.HS9.0000846620.98940.79 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Nørgaard, J. N.
Abildgaard, N.
Lysén, A.
Tsykunova, G.
Vangsted, A. J.
Joao, C.
Remen, N.
Osnes, L.
Connelly, J. P.
Revheim, M.-E. R.
Schjesvold, F.
P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_full P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_fullStr P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_full_unstemmed P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_short P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_sort p938: carfilzomib-lenalidomide-dexamethasone consolidation in myeloma patients with a positive fdg pet/ct after upfront autologous stem cell transplantation: a phase ii study (conpet)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429246/
http://dx.doi.org/10.1097/01.HS9.0000846620.98940.79
work_keys_str_mv AT nørgaardjn p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT abildgaardn p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT lysena p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT tsykunovag p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT vangstedaj p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT joaoc p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT remenn p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT osnesl p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT connellyjp p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT revheimmer p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT schjesvoldf p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet